CHRISTINA PONZIO: Open Payments
NPI 1730513193 · HAMMONTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$620 in 35 payments from 18 companies in 2025. Trend: 2023 $1,650 · 2024 $1,299 · 2025 $620
Food & beverage: $620
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $64 |
| ABBVIE INC. | 4 | $62 |
| Galderma Laboratories, L.P. | 3 | $60 |
| Amgen Inc. | 3 | $52 |
| Organon LLC | 3 | $48 |
| Incyte Corporation | 2 | $46 |
| Botanix SB Inc | 2 | $37 |
| LEO Pharma Inc. | 2 | $33 |
| Arcutis Biotherapeutics, Inc. | 2 | $33 |
| E.R. Squibb & Sons, L.L.C. | 2 | $31 |
Products named: COSENTYX, OTEZLA, SKYRIZI, OPZELURA, NEMLUVIO, SOFDRA, HADLIMA, ADBRY.
Industry payments across NJ — which companies pay providers there.
